SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ROIV

Roivant Sciences Ltd. (NASDAQ:ROIV)

GB · Delayed Price · Currency is USD
Healthcare · Biotechnology
$38.66-$0.30 (-0.78%)
 
Market cap
$28.0B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 8, 2020
Market Cap$28.01B+90.4%
Revenue (ttm)$41.08M+102.1%
Net Income-$344.35M+7.9%
EPS-$0.54+3.6%
Shares Out724.56M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,970,169
Open$38.86
Previous Close$38.96
Day's Range$38.46 - $39.51
52-Week Range$19.96 - $42.50
Beta1.20
AnalystsBuy
Price Target$52.17(+34.96%)
Earnings DateFeb 5, 2027

About ROIV

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.

Address
50 Broadway, London, GL, SW1H 0DB, GB
Market Cap
28.01 billion
Employees
721
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$154.76M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
5 Buy1 Hold0 SellAvg target $43.00 (+11.1%)

6 firms rating ROIV in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From ROIV’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-0.78%
5 Days
-2.04%
1 Month
+3.22%
6 Months
+29.02%
1 Year
+90.42%

$ROIV stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of ROIV by members of U.S. Congress

Lisa C. McClainHouse / RSale$1.00K – $15.00KOct 31, 2025
Lisa C. McClainHouse / RSale$1.00K – $15.00KOct 30, 2025
Lisa C. McClainHouse / RPurchase$1.00K – $15.00KOct 30, 2025
Lisa C. McClainHouse / RPurchase$1.00K – $15.00KJun 17, 2025

Recently reported changes in ROIV holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ROIV's directors and management

Net Shares Purchased by Insiders−4M−2M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ROIV Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ROIV patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ROIV from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ROIV

IJHiShares Core S&P Mid-Cap ETF$754.53M
VTIVanguard Morningstar Total Stock Market ETF$467.37M
VBVanguard Morningstar Small-Cap ETF$418.41M
XMMOInvesco S&P MidCap Momentum ETF$261.76M
VBKVanguard Morningstar Small-Cap Growth ETF$234.19M
VXFVanguard Extended Market ETF$226.81M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ROIV’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Analyst upgrade and Q2 revenue beat offset by significant insider selling; positive clinical and commercial progress provides fundamental support.

Recent Insider Activity

Buys
0
Sells
19
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-38.0 since Aug 21
0255075100Aug 21 — Insider Score 38.0Aug 22 — Insider Score 38.0Aug 23 — Insider Score 38.0Aug 24 — Insider Score 38.0Aug 25 — Insider Score 38.0Aug 26 — Insider Score 37.0Aug 27 — Insider Score 38.0Aug 28 — Insider Score 37.0Aug 29 — Insider Score 37.0Aug 30 — Insider Score 38.0Aug 31 — Insider Score 38.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 26.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

ADPVAdaptiv Select ETF5.89%
ADDSHedgeye Index Adds ETF5.00%
TYNEDirexion Nanotechnology ETF4.65%
PTHInvesco Dorsey Wright Healthcare Momentum ETF4.30%
XMMOInvesco S&P MidCap Momentum ETF4.23%
GDOCGoldman Sachs Future Health Care Equity ETF2.73%
PJFMPGIM Jennison Focused Mid-Cap ETF2.50%
TECHarbor Transformative Technologies ETF (TEC)2.36%
AAUBAlpha Architect US Equity 4 ETF2.26%
MOONDirexion Moonshot Innovators ETF2.05%
IBBQInvesco Nasdaq Biotechnology ETF1.86%
BBPVirtus Biotech ETF1.79%

Weight is the stock’s share of each fund’s holdings.